• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在患有复杂感染性疾病的中国儿童中,实现AUC/MIC≥400所需的万古霉素谷浓度。

Desired vancomycin trough concentration to achieve an AUC /MIC ≥400 in Chinese children with complicated infectious diseases.

作者信息

Zhang Tao, Cheng Hua, Pan Zhenyu, Mi Jie, Dong Yuzhu, Zhang Ying, Sun Dan, Du Qian, Cheng Xiaoliang, Dong Yalin

机构信息

Department of Pharmacy, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.

Department of Pharmacy, The Affiliated Children Hospital of Xi'an Jiaotong University, Xi'an, China.

出版信息

Basic Clin Pharmacol Toxicol. 2020 Jan;126(1):75-85. doi: 10.1111/bcpt.13303. Epub 2019 Aug 28.

DOI:10.1111/bcpt.13303
PMID:31403243
Abstract

A vancomycin steady-state trough concentration (C ) of 15-20 mg/L is recommended for achieving a ratio of the 24-hour area under the curve to the minimum inhibitory concentration (AUC /MIC) of ≥400 in adults. Since few paediatric data are available, our objectives were to (a) measure the pharmacokinetic indices of vancomycin and (b) determine the correlation between C and AUC /MIC in paediatric patients. Population-based pharmacokinetic modelling was performed for paediatric patients to estimate the individual parameters. The relationship between C and the calculated AUC /MIC was explored using linear regression and a probabilistic framework. A sensitivity analysis was also conducted using Monte Carlo simulations. Body-weight significantly influenced the pharmacokinetics of vancomycin. Based on real data and simulations, C ranges of 5.0-5.9 and 9.0-12.9 mg/L were associated with AUC /MIC ≥400 for MIC values of ≤0.5 and ≤1 mg/L, respectively. Vancomycin regimens of 10 and 15 mg/kg every 6 hours achieved a C of 5.0-5.9 mg/L and AUC /MIC ≥400 in >90% of the children when MIC was ≤0.5 mg/L. At a MIC of ≤1 mg/L, vancomycin at 15 mg/kg every 6 hours achieved C of 9.0-12.9 mg/L and AUC /MIC ≥400 in 2.0- and 1.6-fold as many children compared to a dose of 10 mg/kg every 6 hours, respectively. Vancomycin C values of 5.0-12.9 mg/L were strongly predictive of achieving AUC /MIC ≥400, and rational dosing regimens of 10-15 mg/kg q6h were required in paediatric patients, depending on the pathogen.

摘要

对于成年人,推荐万古霉素稳态谷浓度(C)为15 - 20mg/L,以实现24小时曲线下面积与最低抑菌浓度之比(AUC/MIC)≥400。由于儿科数据有限,我们的目标是:(a)测量万古霉素的药代动力学指标;(b)确定儿科患者中C与AUC/MIC之间的相关性。对儿科患者进行基于群体的药代动力学建模以估计个体参数。使用线性回归和概率框架探索C与计算得到的AUC/MIC之间的关系。还使用蒙特卡洛模拟进行了敏感性分析。体重对万古霉素的药代动力学有显著影响。基于实际数据和模拟,当最低抑菌浓度(MIC)值分别≤0.5mg/L和≤1mg/L时,C范围为5.0 - 5.9mg/L和9.0 - 12.9mg/L与AUC/MIC≥400相关。当MIC≤0.5mg/L时,每6小时10mg/kg和15mg/kg的万古霉素给药方案在>90%的儿童中可实现C为5.0 - 5.9mg/L且AUC/MIC≥400。当MIC≤1mg/L时,每6小时15mg/kg的万古霉素方案实现C为9.0 - 12.9mg/L且AUC/MIC≥400的儿童数量分别是每6小时10mg/kg剂量的2.0倍和1.6倍。万古霉素C值为5.0 - 12.9mg/L强烈预示可实现AUC/MIC≥400,儿科患者需要根据病原体采用10 - 15mg/kg q6h的合理给药方案。

相似文献

1
Desired vancomycin trough concentration to achieve an AUC /MIC ≥400 in Chinese children with complicated infectious diseases.在患有复杂感染性疾病的中国儿童中,实现AUC/MIC≥400所需的万古霉素谷浓度。
Basic Clin Pharmacol Toxicol. 2020 Jan;126(1):75-85. doi: 10.1111/bcpt.13303. Epub 2019 Aug 28.
2
Population pharmacokinetics of vancomycin and AUC-guided dosing in Chinese neonates and young infants.万古霉素在中国新生儿和小婴儿中的群体药代动力学及AUC指导下的给药方案
Eur J Clin Pharmacol. 2018 Jul;74(7):921-930. doi: 10.1007/s00228-018-2454-0. Epub 2018 Mar 30.
3
[Study on the optimization of administration regimen of vancomycin in critical patients].[危重症患者万古霉素给药方案的优化研究]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020 Feb;32(2):140-144. doi: 10.3760/cma.j.cn121430-20190905-00026.
4
Vancomycin AUC estimation using first-order pharmacokinetic methods in pediatric patients.利用一阶药代动力学方法估算儿科患者的万古霉素 AUC。
Pharmacotherapy. 2024 Apr;44(4):294-300. doi: 10.1002/phar.2916. Epub 2024 Mar 27.
5
Population pharmacokinetic analysis and dosing regimen optimization of teicoplanin in critically ill patients with sepsis.替考拉宁在重症脓毒症患者中的群体药代动力学分析及给药方案优化
Front Pharmacol. 2023 Apr 28;14:1132367. doi: 10.3389/fphar.2023.1132367. eCollection 2023.
6
Pharmacokinetic/Pharmacodynamic Target Attainment of Vancomycin, at Three Reported Infusion Modes, for Methicillin-Resistant (MRSA) Bloodstream Infections in Critically Ill Patients: Focus on Novel Infusion Mode.三种报告的输注模式下,治疗重症耐甲氧西林金黄色葡萄球菌(MRSA)血流感染时,万古霉素的药代动力学/药效学目标达成情况:新型输注模式重点关注。
Front Cell Infect Microbiol. 2022 Jul 7;12:874401. doi: 10.3389/fcimb.2022.874401. eCollection 2022.
7
Vancomycin population pharmacokinetics and dosing recommendations in haematologic malignancy with augmented renal clearance children.血液恶性肿瘤合并增强肾清除率儿童患者的万古霉素群体药代动力学和剂量推荐
J Clin Pharm Ther. 2020 Dec;45(6):1278-1287. doi: 10.1111/jcpt.13206. Epub 2020 Jun 18.
8
Association between vancomycin trough concentration and area under the concentration-time curve in neonates.新生儿万古霉素谷浓度与浓度-时间曲线下面积之间的关联。
Antimicrob Agents Chemother. 2014 Nov;58(11):6454-61. doi: 10.1128/AAC.03620-14. Epub 2014 Aug 18.
9
Is peak concentration needed in therapeutic drug monitoring of vancomycin? A pharmacokinetic-pharmacodynamic analysis in patients with methicillin-resistant staphylococcus aureus pneumonia.万古霉素治疗药物监测中是否需要达到峰值浓度?耐甲氧西林金黄色葡萄球菌肺炎患者的药代动力学-药效学分析。
Chemotherapy. 2012;58(4):308-12. doi: 10.1159/000343162. Epub 2012 Nov 7.
10
Improved vancomycin dosing in children using area under the curve exposure.采用 AUC 暴露量改善儿童万古霉素的给药剂量。
Pediatr Infect Dis J. 2013 Apr;32(4):e155-63. doi: 10.1097/INF.0b013e318286378e.

引用本文的文献

1
Prediction of Vancomycin Area Under the Curve With Trough Concentrations Only: Performance Evaluation of Pediatric Population Pharmacokinetic Models.仅通过谷浓度预测万古霉素曲线下面积:儿科群体药代动力学模型的性能评估
J Infect Dis. 2025 Jun 2;231(5):e882-e890. doi: 10.1093/infdis/jiaf059.
2
Pharmacokinetics of Vancomycin among Patients with Chemotherapy-Associated Febrile Neutropenia: Which Would Be the Best Dosing to Obtain Appropriate Exposure?化疗相关性发热性中性粒细胞减少症患者中万古霉素的药代动力学:哪种给药方案能获得合适的药物暴露量?
Antibiotics (Basel). 2022 Nov 1;11(11):1523. doi: 10.3390/antibiotics11111523.
3
A Canadian perspective on the revised 2020 ASHP-IDSA-PIDS-SIDP guidelines for vancomycin AUC-based therapeutic drug monitoring for serious MRSA infections.
加拿大人对2020年修订的美国卫生系统药师协会-美国感染病学会-儿科感染病学会-美国传染病药师协会关于基于万古霉素曲线下面积的严重耐甲氧西林金黄色葡萄球菌感染治疗药物监测指南的看法。
J Assoc Med Microbiol Infect Dis Can. 2021 May 3;6(1):3-9. doi: 10.3138/jammi-2020-0028. eCollection 2021 Mar.
4
Heaping the Pelion of Vancomycin on the Ossa of Methicillin-resistant Staphylococcus aureus: Back to Basics in Clinical Care and Guidelines.在耐甲氧西林金黄色葡萄球菌之上堆砌万古霉素之山:临床护理与指南回归基础
Clin Infect Dis. 2021 May 18;72(10):e682-e684. doi: 10.1093/cid/ciaa1360.